Lasa Supergenerics Limited (LASA) — Financial Results | 29 June 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Lasa Supergenerics announced that its trading window closed on June 29, 2026, for designated employees and their immediate relatives until 48 hours after the unaudited quarterly results for June 30, 2026 are declared.

📄 View Original Announcement (PDF)

About Lasa Supergenerics Limited (LASA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹31.41 Cr ROE: -20.2% ROCE: -17.9%

View full LASA stock details →

📡 Get AI alerts when LASA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LASA — Free

📊 More LASA filings

See all LASA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LASA files new disclosures

Track LASA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LASA — Free

Free account · 2 AI queries/day